MediciNova Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, MediciNova stock has a consensus rating of "Strong Buy" and an average price target of $9.00. The average 1-year stock price forecast is 592.31% higher than the current stock price, while the lowest is $6.00 (+361.54%) and the highest is $11 (+746.15%).

Price Target: $9.00 (+592.31%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$9.00	$10	$11
Change	+361.54%	+592.31%	+669.23%	+746.15%

Analyst Ratings

The average analyst rating for MediciNova stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	3	3	2	2
Buy	0	0	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	4	4	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Buy Maintains $6	Buy	Maintains	$6	+361.54%	May 28, 2026
Lander Egana Gorrono H.C. Wainwright	H.C. Wainwright	Buy Maintains $10	Buy	Maintains	$10	+669.23%	May 28, 2026
Elemer Piros Lucid Capital	Lucid Capital	Buy Initiates $11	Buy	Initiates	$11	+746.15%	Jan 5, 2026

Financial Forecast

Revenue This Year

443.50K

from 409.66K

8.26%

from 409.66K

Revenue Next Year

400.00K

from 443.50K

-9.81%

from 443.50K

EPS This Year

-0.26

from -0.24

EPS Next Year

-0.43

from -0.26

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.04M	-	1.00M	-	409.66K	443.50K
Revenue Growth	-	-	-	-	-	8.26%
Gross Profit	4.04M	-	1.00M	-	31.05K	314.89K
Gross Margin	100.00%	-	100.00%	-	7.58%	71.00%
Operating Income	-10.22M	-14.63M	-9.90M	-12.68M	-13.28M	-14.44M
Net Income	-10.13M	-14.07M	-8.57M	-11.05M	-12.00M	-13.50M
EPS	-	-	-	-	-0.24	-0.26
Free Cash Flow	-3.87M	-8.08M	-5.12M	-7.55M	-6.09M	-30.14M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	700,000
Avg	443,500
Low	187,000

Revenue Growth

Revenue Growth	2026	2027	2028
High	70.9%
Avg	8.3%
Low	-54.4%

EPS Forecast

EPS	2026	2027	2028
High	-0.26
Avg	-0.26
Low	-0.26

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-